• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Indivior Pharmaceuticals, Inc. - Common Stock (NQ:INDV)

37.66 +0.88 (+2.39%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Indivior Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Indivior Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance
April 30, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder
April 24, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse
April 16, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th
April 09, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities
March 31, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder
March 17, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering
March 12, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior Announces Proposed Convertible Senior Notes Offering
March 12, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder
March 11, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results
February 26, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior to Participate in Upcoming Investor Conferences
February 24, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26ᵗʰ
January 28, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior Announces Completion of Redomiciliation to the United States
January 26, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior Provides Full-Year 2026 Financial Guidance and Business Update
January 08, 2026
From Indivior Inc.
Via GlobeNewswire
News headline image
INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit with the Schall Law Firm
October 01, 2024
From The Schall Law Firm
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Indivior PLC (INDV)
September 30, 2024
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
INDV Deadline: Rosen Law Firm Urges Indivior PLC (INDV) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
September 29, 2024
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm
September 25, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
ROSEN, A LEADING LAW FIRM, Encourages Indivior PLC Investors to Secure Counsel Before Important October 1 Deadline in Securities Class Action – INDV
September 23, 2024
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
INDIVIOR PLC (NASDAQ: INDV) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Indivior PLC Investors of Upcoming Deadline
September 23, 2024
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm
September 21, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Indivior PLC REMINDER – INDV Stockholders Should Contact Robbins LLP for Information About the Indivior PLC Class Action and Pending Lead Plaintiff Deadline
September 18, 2024
From Robbins LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm
September 17, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm
September 13, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INVESTOR ALERT: DiCello Levitt LLP Shareholder Class Action Lawsuit Filed Against Indivior PLC (NASDAQ: INDV); Investors with Losses Encouraged to Discuss Their Options with Counsel
September 13, 2024
From DiCello Levitt LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm
September 09, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INDIVIOR PLC (NASDAQ: INDV) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Indivior PLC Investors of Upcoming Deadline
September 09, 2024
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm
September 03, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INDIVIOR PLC (NASDAQ: INDV) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Indivior PLC Investors of Upcoming Deadline
September 03, 2024
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm
August 28, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap